2026-04-15 13:45:40 | EST
Earnings Report

BHFAN Brighthouse Financial 5.375% Non-Cumulative Preferred Series C Depositary Shares reports 29.8% Q4 2025 EPS miss, shares edge down 0.6% today. - Days To Cover

BHFAN - Earnings Report Chart
BHFAN - Earnings Report

Earnings Highlights

EPS Actual $3.7
EPS Estimate $5.2677
Revenue Actual $None
Revenue Estimate ***
Real-time US stock market capitalization analysis and size classification for appropriate risk assessment and position sizing decisions. We help you understand how company size impacts volatility and expected returns in different market conditions and economic environments. We provide size analysis, volatility by market cap, and size factor returns for comprehensive coverage. Understand size impact with our comprehensive capitalization analysis and size classification tools for risk management. Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C (BHFAN) recently released its the previous quarter earnings results. The filing reported quarterly EPS of $3.7, with no standalone revenue data disclosed for the series, consistent with standard reporting practices for preferred share depositary instruments tied to a parent firm’s broader capital structure rather than operating as a standalone revenue-ge

Executive Summary

Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C (BHFAN) recently released its the previous quarter earnings results. The filing reported quarterly EPS of $3.7, with no standalone revenue data disclosed for the series, consistent with standard reporting practices for preferred share depositary instruments tied to a parent firm’s broader capital structure rather than operating as a standalone revenue-ge

Management Commentary

During the associated the previous quarter earnings call, BHFAN’s leadership focused heavily on the parent company’s capital adequacy supporting the 5.375% non-cumulative preferred dividend, noting that internal coverage ratios for the series remain within pre-established target ranges as of the end of the quarter. Management directly addressed the absence of standalone revenue data for BHFAN, explaining that the preferred share issue’s performance is tied to Brighthouse Financial’s overall balance sheet health rather than discrete operating revenue streams, so separate revenue disclosures are not required or provided in quarterly filings for this instrument. The team also commented on recent interest rate trends, noting that shifts in benchmark rates have influenced demand for high-yield preferred securities broadly, and that BHFAN’s current yield profile remains aligned with peer insurance sector preferred issues of similar credit quality. Management also confirmed that no proposals to adjust or suspend the preferred series’ regular dividend were under active consideration as of the call, in line with the firm’s stated capital allocation priorities for fixed-income and preferred securities investors. Diversifying the type of data analyzed can reduce exposure to blind spots. For instance, tracking both futures and energy markets alongside equities can provide a more complete picture of potential market catalysts.

Forward Guidance

The forward guidance accompanying the the previous quarter release was focused on maintaining the regulatory and internal capital thresholds required to support the preferred series’ ongoing obligations, with no concrete commitments for future dividend adjustments provided, as is standard for non-cumulative preferred securities where all dividend payments remain at the sole discretion of the company’s board of directors, subject to legal and regulatory requirements. Management noted that potential shifts in macroeconomic conditions, including unanticipated volatility in insurance market liabilities, sharp moves in benchmark interest rates, or broader market dislocations, could potentially impact the capital position supporting the BHFAN series in upcoming periods. Based on publicly available market data, analysts estimate that BHFAN’s current operating framework would likely support ongoing dividend payments under baseline macroeconomic scenarios, though no guarantees of this outcome have been provided by the firm. Investors who keep detailed records of past trades often gain an edge over those who do not. Reviewing successes and failures allows them to identify patterns in decision-making, understand what strategies work best under certain conditions, and refine their approach over time.

Market Reaction

In the trading sessions immediately following the the previous quarter earnings release, BHFAN saw trading volume roughly in line with recent average levels, with no extreme price volatility observed as of this analysis. Analyst notes published after the call highlighted that the reported $3.7 EPS figure aligned with broad market expectations for the series, with no material unexpected disclosures included in the release or call that would shift investor sentiment materially. Market participants focused heavily on management’s commentary around dividend coverage, which was viewed as consistent with prior public disclosures, leading to muted near-term trading action in the security. Preferred market analysts have noted that investor interest in BHFAN may continue to track broader trends in high-yield fixed income and insurance sector securities in upcoming weeks. Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Real-time data can reveal early signals in volatile markets. Quick action may yield better outcomes, particularly for short-term positions.
Article Rating 81/100
4521 Comments
1 Jyrah Trusted Reader 2 hours ago
I read this like I was being tested.
Reply
2 Stokely Returning User 5 hours ago
US stock product cycle analysis and innovation pipeline tracking to understand future growth drivers and upcoming catalysts for stock appreciation. Our product research helps you identify companies with upcoming catalysts that could drive significant stock price appreciation in the future. We provide product pipeline analysis, innovation scoring, and catalyst tracking for comprehensive coverage. Find future winners with our comprehensive product cycle analysis and innovation tracking tools for growth investing.
Reply
3 Jakevion Regular Reader 1 day ago
Anyone else want to talk about this?
Reply
4 Beleta New Visitor 1 day ago
Really regret not reading sooner. 😭
Reply
5 Yajur Registered User 2 days ago
This kind of delay always costs something.
Reply
Disclaimer: Not investment advice. Earnings data is based on company reports and analyst estimates. Past performance does not guarantee future results.